Three things to know:
1. The registration allows BioFirma to package, process, store, label and distribute human cells and tissue.
2. IMAC began using BioFirma’s NeoCyte regenerative medicine products in its rehabilitation clinics.
3. BioFirma now sells amniotic fluid exosomes to physicians in the U.S. and reported $80,000 from the product’s sales during the second quarter of 2019.
More articles on biologics:
Misonix ultrasonic device earns CE Mark approval — 4 insights
Laser Spine Institute co-founders now owe ex-business partner $300M+, judge rules
Academic panel to define best practices for outpatient stem cell procedure
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
